Loading clinical trials...
Loading clinical trials...
Phase II Study of LCL161 Alone and in Combination With Cyclophosphamide in Patients With Relapsed or Refractory Multiple Myeloma
Conditions
Interventions
Cyclophosphamide
Laboratory Biomarker Analysis
+3 more
Locations
3
United States
Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
November 1, 2013
Primary Completion Date
June 9, 2016
Completion Date
December 27, 2016
Last Updated
September 10, 2019
NCT05312255
NCT04508790
NCT04640779
NCT05288062
NCT02765854
NCT05191472
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions